DOCSLIB.ORG

PATH to the FUTURE a Publication of the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PATH to the FUTURE a Publication of the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine Winter Issue 2009-2010 Volume 3 Issue 4 PATH TO THE FUTURE A Publication of the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine IN MEMORY Dr. Willam ‘Joe’ Moores Hospital in 1987 and 1989, Most Distinguished Inside Medical Alumnus from IUSM in 1989, Spirit 1 August 5, 1938 - August 23, 2009 of Philanthropy Award from IUPUI in 1989, In Memory Bowen’s Distinguished Leadership Award Dr. William “Joe” Moores form IUSM in 1993, 1996 and 1997, Hero of Medicine from IUSM in 1995, Methodist Hos- pital Outstanding Physician Alumnus Award 2 (in recognition of more than 30 years of dedi- New Faculty cated service to the community and medical Dr. Howard Wu profession) in 1999 and the IU Foundation first Keystone Award in 2007. 2 A celebration of Dr. Moores’ life was held Faculty Honors on August 30th at Scholars Hall, University Dr. Ghetti Honored by FDA Place Hotel on the IUPUI campus. Dean of the IUSM, Dr. Craig Brater spoke at the memo- Dr. Badve - FOXA1 Biomarker rial. Eugene Tempel, Ed.D., President of the IU Foundation and Dr. Christopher Rehme, 3 illiam B. “Joe” Moores lost his fight with President of Dermatology Incorporated and a Wbrain cancer on August 23, 2009 at the close friend of Dr. Moores spoke that day as well. New Fellows age of 71. Dr. Moores When Eugene Temple spoke of Dr. Moores was born on August Friend... New Residents he recalled William B. “Call me Joe” Moores 5, 1938 in Indianapo- as just a regular guy who was larger than life, lis. He married Ree committing, “This regular guy was also a mav- 4 Rice in 1959 and they erick and trailblazer.” History of the Department had two girls, Mindy of Pathology and and Kirsten. Dr. Temple remembers in 2007 when Dr. Moores was named a “Partner in Philanthropy” by the IU Dr. Moores graduated Laboratory Medicine Foundation and was presented with the Keystone from Indiana Univer- Written by Dr. Kathleen Warfel Hull, Emeritus Award. This award is given Professor sity School of Medi- by the foundation to recog- cine (IUSM) in 1963. Colleague... nize outstanding friends of He continued here to complete a residency in IU and their exemplary and 7 dermatology in 1968 after a one year internship long-term leadership in phi- Gift to the Department at Methodist Hospital. His was board certifi- lanthropy. Dr. Temple sees Gift to the Research and Education Fund cated in dermatology in 1969 and was certified from Mildred Young’s Estate the “keystone” as a perfect in dermatopathology in 1981. Dr. Moores was description of Dr. Moores. dedicated to teaching dermatology and der- The keystone is the stone matopathology, inspiring hundreds of medical 8 that keeps all others from students and residents throughout his career. Remembering Joe Moores He was a Clinical Professor of Dermatol- Teacher... ogy for many years and became the Director Fellowship Gift Card collapsing on them. of Dermatopathology for the department in “Joe was our key- 2002, which he held until his passing. stone,” remarked Dr. Moores was presented with many awards Dr. Tempel. He wit- over his 40 years as a professor. A few include nessed Dr. Moores the IUSM Certificate of Meritorious Service in hold together cam- 1977, Special Commendation for Teaching from paigns, friends, the Indiana Dermatologic Society in 1987, Dis- colleagues, and tinguished Teaching Award from Methodist many more. “In Memory” continued on page 8 Path to the Future Path to the Future Path to the Future is NEW FACULTY NEW FELLOWS Mohammed Abuel-Haija, MBBS, Hematopathology Becky Marks, M.D., Cytopathology published bi-annually for Hospital since 1994 and the Associate Pro- Howard Her- alumni and friends of Juing Wu, MD gram Director for the Pathology Residency Dr. Abuel-Haija received his MBBS degree in Dr. Marks received her medical degree from IUSM Program since 1999. Dr. Wu received his Medicine and Surgery from the University of Jor- Dr. Howard Wu is joining (2005). She continued here at IUMS to complete her medical degree from Kaohsiung Medical dan School of Medicine (2002). He completed his our department in Janu- residency training in Clinical and Anatomic Pathol- University in Taiwan in 1984. After two residency training at Temple University Hospital in ary 2010 as an Associate ogy (2009). years of mandatary military service, he Anomic Pathology and Clinical Pathology (2009). Professor of Pathology completed a one year residency in pathol- and Laboratory Medi- INDIANA UNIVERSITY ogy at Chung-Gung Memorial Hospital, cine in the Anatomic John Fasig, M.D., Cytopathology Trent McBride, M.D., Hematopathology DEPARTMENT OF PATHOLOGY Taipei, Taiwan (1987). Dr. Wu completed Pathology section. Dr. Wu is currently the AND LABORATORY MEDICINE an AP/CP residency at Ball Memorial Hos- Dr. Fasig received his medical degree from the Director of Surgical Pathology at Ball Me- Dr. McBride received his medical degree (2005) and School of Medicine pital in 1994, followed by a fellowship in Carver College of Medicine at the University of morial Hospital and the East Central Indi- completed his residency (2007) from the Univer- Cytopathology at IU School of Medicine in Iowa (2003). He completed his residency training sity of Kentucky College of Medicine. Recently, he ana Pathologist PC in Muncie, a position 1996. Dr. Wu is board certified in AP/CP at Vanderbilt University (2007). He also completed worked as a Gross Room Technician for the Lexing- Van Nuys Medical Science Building he has held since October of 2000. He has a fellowship in Anatomic Pathology at Vanderbilt and Cytopathology. ■ ton Clinic, Department of Pathology. 635 Barnhill Drive, Room A-128 been on the clinical staff at Ball Memorial University Medical Center (2008). Indianapolis, IN 46202-5120 FACULTY HONORS Matthew Hagan, M.D, PhD, Neuropathology Marzena Muller, M.D., Surgical Pathology Phone 317-274-1738 ommendations regarding the regulation Dr. Muller received her medical degree from Ross Dr. Ghetti Honored by FDA Dr. Hagan received his medical degree from the Fax 317-278-2018 of these products. TSEs, also known University School of Medicine in Dominica, West The Food and Drug University of Minnesota-Minneapolis School of www.pathology.iupui.edu Indies (2000). She completed her residency training Administration has as prion diseases, are a group of rare Medicine where he chose the combined MD/PhD at Ball Memorial Hospital in Muncie (2006). She recognized Bernardino degenerative brain disorders character- program (2005). His PhD is in Neuroscience. He completed a Cytopathology fellowship at Allegheny Ghetti, MD with an ized by tiny holes that give the brain a completed his residency training here at IUSM General Hospital in Pittsburgh (2007). Recently, Dr. award for his distin- “spongy” appearance. (2009). Chairman — Muller worked for Great Lakes Pathologists. guished service as a Dr. Ghetti is currently the director of John N. Eble MD, MBA member of the Trans- the division of neuropathology for our Shams Halat, M.D., Genitourinary Pathology Swarna Sikdar, M.D., Cytopathology Dr. Sikdar received her medical degree from Drexel missible Spongiform department and director of the Indi- Dr. Halat received her medical training at the Amer- Senior Administrative Officer— University College of Medicine (2004) in Phila- Encephalopathies (TSEs) Advisory ana Alzheimer Disease Center. Here at ican University of Beirut, Lebanon (2001). She com- delphia. She completed her residency training at Susan M. Hill DLM, MS Committee. pleted her residency training at University Hospitals IU School of Medicine, he holds the St. Luke’s-Roosevelt Hospital Center in New York Case Medical Center in Cleveland, Ohio (2008). The TSEs Advisory Committee, part titles of Distinguished Professor of Pa- (2008). Recently, she completed a fellowship in He- Adminstrative Officer— She completed a fellowship in Cytopathology at the of the Department of Health & Human thology and Laboratory Medicine and matopathology at Washington University School of Julie Lindsley MT, SM Hospital of the University of Pennsylvania (2009). Services, Food and Drug Administra- Chancellor’s Professor. Since his faculty Medicine (2009). appointment in 1976, Dr. Ghetti has tion, reviews and evaluates the safety of Matt Kuhar, M.D., Dermatopathology Raul Villanueva, M.D., Microbiology products that may be at risk for trans- served as a professor of pathology, psy- mission of spongiform encephalopa- chiatry, medical and molecular genetics Dr. Villanueva received his medical degree from Path to the Future editor: thies. The committee then makes rec- and neurology. ■ Dr. Kuhar received his medical degree from Drex- Loma Linda University School of Medicine in Loma Sandee Black el University College of Medicine in Philadelphia Linda, California (2005). He completed his resi- Dr. Badve - FOXA1 ti-estrogen hormone therapies as an alterna- (2005). He completed his residency training her at dency training at Loma Linda University Medical [email protected] Dr. Sunil Badve, as- tive to traditional chemotherapy treatments. IUSM where he was named Chief Resident (2009). Center (2009) where he was named Chief Resident sociate professor of pa- Earlier this year, FOXA1 was licensed by in 2008. thology and laboratory Clarient Inc., a cancer diagnostics company. medicine, along with Clarient stated in the company’s press re- his research colleague lease, the marker is a “significant new addi- NEW RESIDENTS Harikrishna Nakshatri, tion to our Clarient Insight® Dx program, Mission Statement- B.V.Sc., Ph.D. and re- which aims to provide pathologists and Photo courtesy of IUPUI search team have de- The Department of Pathology and Labo- Office of Communications oncologists with a panel of assays that help ratory Medicine will be an international and Marketing veloped a new breast deliver personalized medicine in a commu- cancer diagnostic marker called FOXA1 or Dr. Julia Adams Julia Dr. Dr. Annie Marshall Dr.
Load more

Recommended publications
  • Lessons from the African Teledermatology Project
    Report The role of dermatopathology in conjunction with teledermatology in resource-limited settings: lessons from the African Teledermatology Project Matthew W. Tsang1, MD, MSt, and Carrie L. Kovarik2, MD 1Department of Dermatology, University Abstract of Minnesota, Minneapolis, MN, USA, Background Access to dermatology and dermatopathology services is scarce in 2 and, Departments of Dermatology and sub-Saharan Africa. Teledermatology provides consultations for healthcare providers in Internal Medicine, University of resource-limited settings where specialty medical services are difficult to obtain, and the Pennsylvania, Division of Infectious Diseases, Philadelphia, PA, USA African Teledermatology Project has helped to bridge the gap in dermatological care in Africa. This program also allows for biopsy specimens to be sent to the USA for processing Correspondence in cases where the clinical diagnosis is difficult and definitive diagnosis has implications for Carrie Kovarik, MD patient management. This study characterizes conditions diagnosed through clinicopatho- Assistant Professor logical correlation in conjunction with photos and tissue submitted to the African Dermatology, Dermatopathology, and Infectious Diseases Teledermatology Project. University of Pennsylvania Materials and methods Retrospective case review of tissue specimens submitted over 2 Maloney Building three years. 3600 Spruce Street Results Fifty-five biopsy specimens met inclusion criteria and represent cases of Philadelphia, PA 19104 malignancy (35%), infection (7%), suspected infection (15%), lichenoid tissue reaction E-mail: [email protected] (5%), dermatitis (15%), and other various conditions (18%). Three biopsy specimens were Funding sources: None. non-diagnostic (5%). Clinicopathological concordance between submitting clinician and Disclosures: The authors have no biopsy results occurred in 32 out of 55 cases (58%).
    [Show full text]
  • Artificial Intelligence in Dermatopathology
    Review Artificial Intelligence in Dermatopathology: New Insights and Perspectives Gerardo Cazzato 1,* , Anna Colagrande 1, Antonietta Cimmino 1, Francesca Arezzo 2, Vera Loizzi 2 , Concetta Caporusso 1, Marco Marangio 3, Caterina Foti 4, Paolo Romita 4, Lucia Lospalluti 4, Francesco Mazzotta 5, Sebastiano Cicco 6 , Gennaro Cormio 2 , Teresa Lettini 1 , Leonardo Resta 1 , Angelo Vacca 6 and Giuseppe Ingravallo 1,* 1 Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, 70124 Bari, Italy; [email protected] (A.C.); [email protected] (A.C.); [email protected] (C.C.); [email protected] (T.L.); [email protected] (L.R.) 2 Section of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, 70124 Bari, Italy; [email protected] (F.A.); [email protected] (V.L.); [email protected] (G.C.) 3 Section of Informatics, University of Salento, 73100 Lecce, Italy; [email protected] 4 Section of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, 70124 Bari, Italy; [email protected] (C.F.); [email protected] (P.R.); [email protected] (L.L.) 5 Pediatric Dermatology and Surgery Outpatients Department, Azienda Sanitaria Locale Barletta-Andria-Trani, 76123 Andria, Italy; [email protected] 6 Section of Internal Medicine, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, 70124 Bari, Italy; [email protected] (S.C.); [email protected] (A.V.) * Correspondence: [email protected] (G.C.); [email protected] (G.I.) Citation: Cazzato, G.; Colagrande, A.; Abstract: In recent years, an increasing enthusiasm has been observed towards artificial intelligence Cimmino, A.; Arezzo, F.; Loizzi, V.; and machine learning, involving different areas of medicine.
    [Show full text]
  • The Dermatopathology Milestone Project
    The Dermatopathology Milestone Project A Joint Initiative of The Accreditation Council for Graduate Medical Education, The American Board of Dermatology, and The American Board of Pathology July 2015 The Dermatopathology Milestone Project The Milestones are designed only for use in evaluation of fellows in the context of their participation in ACGME- accredited residency or fellowship programs. The Milestones provide a framework for the assessment of the development of the fellow in key dimensions of the elements of physician competency in a specialty or subspecialty. They neither represent the entirety of the dimensions of the six domains of physician competency, nor are they designed to be relevant in any other context. i Dermatopathology Milestones Chair: James W. Patterson, MD Working Group Advisory Group Laura Edgar, EdD, CAE C. Bruce Alexander, MD Tammie Ferringer, MD Julia C. Iezzoni, MD Jessica Kozel, MD Rebecca Johnson, MD Mary Stone, MD Wesley Y. Naritoku, MD, PhD Sharon Weiss, MD ii Milestone Reporting This document presents Milestones designed for programs to use in semi-annual review of fellow performance and reporting to the ACGME. Milestones are knowledge, skills, attitudes, and other attributes for each of the ACGME competencies organized in a developmental framework from less to more advanced. They are descriptors and targets for fellow performance as a fellow moves from entry into fellowship through graduation. In the initial years of implementation, the Review Committee will examine Milestone performance data for each program’s fellows as one element in the Next Accreditation System (NAS) to determine whether fellows overall are progressing. For each period, review and reporting will involve selecting milestone levels that best describe each fellow’s current performance and attributes.
    [Show full text]
  • Dermatopathology
    Dermatopathology Clay Cockerell • Martin C. Mihm Jr. • Brian J. Hall Cary Chisholm • Chad Jessup • Margaret Merola With contributions from: Jerad M. Gardner • Talley Whang Dermatopathology Clinicopathological Correlations Clay Cockerell Cary Chisholm Department of Dermatology Department of Pathology and Dermatopathology University of Texas Southwestern Medical Center Central Texas Pathology Laboratory Dallas , TX Waco , TX USA USA Martin C. Mihm Jr. Chad Jessup Department of Dermatology Department of Dermatology Brigham and Women’s Hospital Tufts Medical Center Boston , MA Boston , MA USA USA Brian J. Hall Margaret Merola Department of Dermatology Department of Pathology University of Texas Southwestern Medical Center Brigham and Women’s Hospital Dallas , TX Boston , MA USA USA With contributions from: Jerad M. Gardner Talley Whang Department of Pathology and Dermatology Harvard Vanguard Medical Associates University of Arkansas for Medical Sciences Boston, MA Little Rock, AR USA USA ISBN 978-1-4471-5447-1 ISBN 978-1-4471-5448-8 (eBook) DOI 10.1007/978-1-4471-5448-8 Springer London Heidelberg New York Dordrecht Library of Congress Control Number: 2013956345 © Springer-Verlag London 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work.
    [Show full text]
  • DERMATOPATHOLOGY Resident Training in Dermatopathology
    1 DERMATOPATHOLOGY Resident training in dermatopathology includes a monthly glass slide conference at UMMC and a required one-month rotation at Dermatopathology Associates PLLC, both taught by Drs. Billy Walker and Jennifer Schulmeier, board-certified dermatopathologists. In addition, residents will sign out skin cases with the surgical pathology faculty when rotating on general surgical pathology at UMMC. Elective rotations at the senior level are also available with Drs. Walker and Schulmeier. Objectives for Six General Competencies Skill level 1 1. Patient Care A. Understand proper collection and processing of skin specimens. B. Be familiar with various methods of cutting skin specimens, with particular attention to surgical margins and how to best represent the gross lesion. C. Correlate clinical information with gross/microscopic findings. D. Know circumstances in which the clinician should be contacted for additional information. E. Know when and how to order special stains F. Familiarity with various fixatives G. Know the indications for, and be able to manage, frozen sections on skin specimens. 2. Medical Knowledge A. As part of the monthly unknown skin slide conference, read each chapter in Lever’s Histopathology of the Skin B. Thoroughly evaluate unknown glass slides prior to the monthly conference, to include differential diagnosis, clinical presentation, prognosis, and treatment. C. Recognize and diagnose common skin conditions on skin biopsies D. Recognize a biopsy as representing an uncommon skin condition which might merit subspecialty referral. Obtain consultation from Drs. Walker and Schulmeier E. Discuss the etiology, pathogenesis and treatment of common skin neoplasms, including melanoma, SCC of skin, basal cell carcinoma, etc.
    [Show full text]
  • Collision of Melanoma and Keratoacanthoma
    Case Report Case Report AA WolfWolf in in Sheep’s Sheep’s Clothing: Clothing: Collision Collision of of Melanoma Melanoma and andKeratoacanthoma Keratoacanthoma 1, 1 2 MatthiasMatthias Walther Walther *,1,*, Sandra Sandra Falkvoll Falkvolland 1 and Sebastian Sebastian Leibl Leibl 2 1 1 Skinmed—ClinicSkinmed—Clinic forfor Dermatology,Dermatology, 5000 5000 Aarau, Aarau, Switzerland; Switzerland; [email protected] [email protected] 2 2 Skinpath—Histopathology,Skinpath—Histopathology, 5600 5600 Lenzburg, Lenzburg Switzerland;, Switzerland; [email protected] [email protected] ** Correspondence:Correspondence: [email protected]@skinmed.ch Abstract:Abstract:Collision Collision tumorstumors consistingconsisting ofof melanomamelanoma andand squamoussquamous cellcell carcinomacarcinoma areare veryvery rare.rare. WeWe presentpresent the the casecase ofof aa deceptivedeceptive hyperkeratotichyperkeratotic nodule nodule on onthe theforearm forearm of ofa a 72-year-old72-year-old woman, woman, which which clinicallyclinically appeared appeared to to be be a squamousa squamous cell cell carcinoma, carcinoma, keratoacanthoma keratoacanthoma type. type Histological. Histological examination examina- surprisinglytion surprisingly revealed revealed a coexisting a coexisting epithelioid epithelioid melanoma. melanoma. Thus, this Thus, case this report case shows report the shows importance the im- ofportance an early of histopathological an early histopathological and immunohistochemical and immunohistochemical workup to preventworkup
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • Review Article Simulators of Squamous Cell Carcinoma of the Skin: Diagnostic Challenges on Small Biopsies and Clinicopathological Correlation
    Hindawi Publishing Corporation Journal of Skin Cancer Volume 2013, Article ID 752864, 10 pages http://dx.doi.org/10.1155/2013/752864 Review Article Simulators of Squamous Cell Carcinoma of the Skin: Diagnostic Challenges on Small Biopsies and Clinicopathological Correlation Kong-Bing Tan,1 Sze-Hwa Tan,1 Derrick Chen-Wee Aw,2 Huma Jaffar,2 Thiam-Chye Lim,3 Shu-Jin Lee,4 and Yoke-Sun Lee1 1 Department of Pathology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Lower Kent Ridge Road, Singapore 119074 2 University Medicine Cluster, National University Health System, Singapore 119074 3 University Surgical Cluster, National University Health System, Singapore 119074 4 Departments of Otorhinolaryngology and Hand and Reconstructive Microsurgery, National University Health System, Singapore 119074 Correspondence should be addressed to Kong-Bing Tan; kong bing [email protected] Received 8 May 2013; Revised 30 May 2013; Accepted 30 May 2013 Academic Editor: Giuseppe Argenziano Copyright © 2013 Kong-Bing Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Squamous cell carcinoma (SCC) is a common and important primary cutaneous malignancy. On skin biopsies, SCC is characterized by significant squamous cell atypia, abnormal keratinization, and invasive features. Diagnostic challenges may occasionally arise, especially in the setting of small punch biopsies or superficial shave biopsies, where only part of the lesion may be assessable by the pathologist. Benign mimics of SCC include pseudoepitheliomatous hyperplasia, eccrine squamous syringometaplasia, inverted follicular keratosis, and keratoacanthoma, while malignant mimics of SCC include basal cell carcinoma, melanoma, and metastatic carcinoma.
    [Show full text]
  • Dermatopathology
    76A ANNUAL MEETING ABSTRACTS of the nodules aspirated was 1.8 (NNAN), 3.2 (HA), 3.0 (HCa) and 2.9 (PTC). The average numbers of nodules identified by US were 3.3 in NNAN, 2.0 in HA, 1.7 in HCa, Dermatopathology and 1.8 in PTC (p<0.05). Furthermore, 40% (4 of 10) and 20% (2 of 10) of HCa were vascularized and microcalcified on US, respectively; and 50% (7 of 14) of NNAN had 337 CD10 and Ep-CAM Expression in Basal Cell Carcinoma, Classical multiple (5) small nodules in the background thyroid. FNA Findings – the Hurthle cell Trichoepithelioma, and Desmoplastic Trichoepithelioma tumors had more cellular smears, discohesive Hurthle cells, few, if any, lymphocytes, TE Abbott, MD Cole, JW Patterson, MR Wick. University of Virginia Health System, and scarce or absent colloid in comparison to the smears from NNAN. Charlottesville, VA. Conclusions: Dominant thyroid nodules 2 cm or less on US without evidence of Background: The distinction between basal cell carcinoma (BCC) and increased vascularity or microcalcifications in combination with the background trichoepithelioma (TE) has historically been made on the basis of specific histologic thyroid containing multiple (3 or more) smaller nodules and the FNA smears containing criteria, but it may be difficult when the tumor sample is limited. Recent reports have some lymphoid aggregates with Hurthle cells in moderately sized sheets are likely to suggested a utility for CD10 and Ep-CAM immunostaining in recognizing BCC. be benign. Communication between clinician and pathologist correlating US and FNA Accordingly, this study was initiated in order to determine whether those markers findings in difficult cases may avoid unnecessary surgery.
    [Show full text]
  • Dermatopathology Laboratory
    Dermatology Dermatopathology Laboratory Dermatopathology is an essential DERMATOPATHOLOGY TESTING SerVICES component for correct diagnosis and treat- Skin biopsy review ment of skin disorders. Our laboratory offers Professional dermatopathology laboratory services comprehensive microscopic diagnosis for Technical dermatopathology laboratory services nail, hair and skin conditions. Our team con- Consultative review (second opinion) of pathology slides sists of four Board Certified Dermatologists Special stains and Dermatopathologists, Anneli R. Bowen, Immunohistochemistry (extensive list of antibodies) M.D., Keith L. Duffy, M.D., Scott R. Florell, M.D., and David A. Wada, M.D., all of whom ENhaNCED CUStomer SerVICES are trained in clinical dermatology and evaluate patients at the University of Utah Timely reporting Health Care Dermatology Clinics in addition Local courier services and prepaid expedited shipping to interpreting dermatopathology speci- Complimentary test request forms, biopsy fixatives and shipping supplies mens. Their expertise covers a wide range of Laboratory services billing department neoplastic and inflammatory skin diseases. Extensive participating insurance list CONTACT US Our Dermatopathology Laboratory Client Services Office is open from 8 a.m. - 5 p.m., Mountain Time, Monday – Friday. We will return all calls and inquires received after business hours the next business day. Dermatopathology LABoratory Department of Dermatology, University of Utah Health Care 30 North 1900 East, 4A330 SOM, Salt Lake City, Utah 84132 Phone: (801) 585-0221 Toll-Free: 1-844-988-7284 (1-844-9UU-PATH) University of Utah Dermatopathology Laboratory participates Fax: (801) 581-6484 in the College of American Pathologists (CAP) Laboratory Email: [email protected] Accreditation Program and has Clinical Laboratory Improvement Amendments (CLIA) certification through the Centers for dermatopathology.uofumedicine.org Medicare & Medicaid Services (CMS).
    [Show full text]
  • Polymerase Chain Reaction-Based Molecular Diagnosis of Cutaneous Infections in Dermatopathology Brian L
    Polymerase Chain Reaction-Based Molecular Diagnosis of Cutaneous Infections in Dermatopathology Brian L. Swick, MD*,† Conventional methods, including microscopy, culture, and serologic studies, are a mainstay in the diagnosis of cutaneous infection. However, owing to limitations associated with these techniques, such as low sensitivity for standard microscopy and in the case of culture delay in diagnosis, polymerase chain-reaction based molecular techniques have taken on an expanding role in the diagnosis of infectious processes in dermatopathology. In particular, these assays are a useful adjunct in the diagnosis of cutaneous tuberculosis, atypical mycobacterial infec- tion, leprosy, Lyme disease, syphilis, rickettsioses, leishmaniasis, and some fungal and viral infections. Already in the case of tuberculosis and atypical mycobacterial infection, standard- ized polymerase chain-reaction assays are commonly used for diagnostic purposes. With time, additional molecular-based techniques will decrease in cost and gain increased standardiza- tion, thus delivering rapid diagnostic confirmation for many difficult-to-diagnose cutaneous infections from standard formalin-fixed paraffin-embedded tissue specimens. Semin Cutan Med Surg 31:241-246 © 2012 Frontline Medical Communications KEYWORDS molecular diagnosis, infections, PCR, polymerase chain reaction, dermatopathol- ogy, dermatology onventional methods for the diagnosis of cutaneous infec- can detect small amounts or DNA or RNA, they can serve to Ction in dermatopathology include those performed directly quickly identify microorganisms that are present in small num- by the dermatopathologist, such as microscopy using histo- bers in a clinical sample, stain poorly with conventional tech- chemical stains and antigen detection using immunohistochem- niques, or are unculturable.2 The application of PCR-based mo- ical (IHC) methods, as well as adjunctive laboratory techniques, lecular techniques to the diagnosis of common infectious including culture and serologic studies.
    [Show full text]
  • Frequently Asked Questions: Dermatopathology Review Committee for Dermatology ACGME
    Frequently Asked Questions: Dermatopathology Review Committee for Dermatology ACGME Question Answer Educational Program How does the Review Committee define “direct inspection” “Direct inspection” refers to the assessment of primary and secondary in reference to diagnosing skin disorders, and in what skin lesions and their distribution on the body surface, resulting in the contexts does the Review Committee expect fellows will generation of a reasonable differential diagnosis and a determination of acquire this experience? the most likely clinical diagnosis. Fellows who are dermatologists should already have acquired this skill. [Program Requirement: IV.A.2.a).(2)] Fellows who are pathologists will have these same experiences, but will spend 50% of eight months of their 12-month fellowship examining patients in a dermatology clinic setting. In the clinic, direct inspection of lesions may be enhanced by techniques such as dermoscopy and Wood's light examination. Direct inspection related to the examination of gross specimens removed from the patient is more limited in scope, but can also provide useful information. This takes place most often in the grossing room, and would probably be encountered more often by dermatology- educated fellows rotating in surgical pathology. Examples include assessments of irregular pigmentation, hemorrhage, or blistering, each of which may prompt a differential diagnosis or considerations about where sectioning of a specimen should be obtained. What does the Review Committee expect as far as a The Review Committee considers examination to include the following fellow’s examination of dermatology patients? that must be done by the fellow: 1. take a history focused on the skin issues; [Program Requirement: IV.A.3.a).(2).(a)] 2.
    [Show full text]